Skip to content

Insulet PODD Shares (Diluted)

Shares (Diluted) at other companies

Eli Lilly logo
Eli LillyLLY
895.9M-0.5%
Medtronic logo
MedtronicMDT
1.3B-0.1%
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
72.4M-0.8%
Abbott logo
AbbottABT
1.7B0.0%
Viatris logo
ViatrisVTRS
1.2B-1.4%

Other financials

Income statement

See full
Revenue$761.7M+33.9%
Gross profit$529.0M+29.3%
Operating income$122.1M+37.5%
Net income$91.1M+157%
EPS (diluted)$1.30+160%

Balance sheet

See full
Cash & equivalents$480.4M-62.6%
Total debt$969.7M-45.5%
Total equity$1.3B-2.1%
Total assets$3.0B-15.1%

Cash flow

See full
Operating cash flow$113.8M+78.4%
CapEx$24.3M+97.6%
Free cash flow$89.5M+73.8%

Valuation

See full
Market cap$10.1B-19.9%
Enterprise value$10.59B-19.4%
P/E33.3×+2.0×
P/S3.5×-2.3×

Profitability

See full
Gross margin71%+0.6pp
Operating margin17.5%+2.0pp
Net margin10.4%-7.9pp
FCF margin14.3%+1.1pp

Returns & leverage

See full
Return on equity23%-14.9pp
Debt / equity0.7×-0.6×
Current ratio2.5×-2.0×

Where this comes from

Reported directly by Insulet in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The official record: Insulet’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Insulet's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Insulet's shares (diluted)?
Insulet (PODD) reported shares (diluted) of 70.2M in Q1 2026.
How has Insulet's shares (diluted) changed year-over-year?
Insulet's shares (diluted) decreased by 5.3% year-over-year, from 74.1M to 70.2M.
What is the long-term trend for Insulet's shares (diluted)?
Over 4 years (2021 to 2025), Insulet's shares (diluted) has grown at a 1.5% compound annual growth rate (CAGR), from 271M to 287.3M.
What does shares (diluted) mean?
The average number of shares including all potential future shares from options or debt.
How do you interpret shares (diluted)?
A significant increase relative to basic shares may signal high levels of employee stock-based compensation or convertible debt obligations.
How does shares (diluted) compare across companies?
Standard metric for assessing the impact of equity-based incentive plans common in the high-growth medical device sector.